FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004662209> ?p ?o ?g. }

• W2004662209 endingPage "676" @default.
• W2004662209 startingPage "669" @default.
• W2004662209 abstract "The treatment of carotid artery stenosis currently constitutes a major component of vascular surgical practice. Carotid angioplasty and stenting (CAS), however, is mainly performed by nonvascular surgeon interventionalists with cerebral protection devices available only through investigational protocols. This study reports the initial results of a CAS program initiated and performed by vascular surgeons using commercially available cerebral protection devices. Fifty-seven patients were enrolled in the study over a 14-month period. All patients were at high risk for conventional endarterectomy (7 resentosis, 4 irradiation, and 46 medically high-risk ASA III). Mean age was 75.7 years (range, 45-93 years). High-grade stenosis of the carotid artery was present in all cases (mean stenosis, 85%; range, 80-99%). Twenty-four percent of patients were symptomatic. Cerebral protection was performed with an occlusion balloon-wire in 32 cases and with a filter-wire device in 24; no cerebral protection was used in 1 patient with restenosis after endarterectomy. Initially in the study, atropine was administered selectively for the development of bradycardia. Currently atropine is administered routinely prior to the initial balloon angioplasty of the carotid bulb. Clopidogrel (75 mg/day) was administered for 5 days prior to CAS and for 30 days after CAS. All 57 patients underwent successful dilatation of their carotid stenoses without occlusion or dissection. Ten of 32 patients in whom balloon occlusion was used for cerebral protection exhibited transient evidence of cerebral ischemia during protection balloon occlusion. These symptoms resolved completely without permanent neurological deficit in all cases. Development of bradycardia with a heart rate <50 bpm was significantly reduced by routine administration of atropine prior to the initial dilatation within the carotid bulb (p = 0.01). Mean hospital length of stay was 1.33 days (range, 1-5 days). There were two periprocedure myocardial infarctions, two postprocedure transient ischemic attacks, and one reversible ischemic neurologic deficit. There was no 30-day mortality. There have been no instances of hemodynamically significant restenosis during a mean follow-up period of 5.4 months. From these results we have concluded that CAS can be performed effectively and safely using commercially available cerebral protection devices. A program initiated and performed exclusively by vascular surgeons is effective and should be the standard model used in the endovascular treatment of carotid artery stenosis." @default.
• W2004662209 created "2016-06-24" @default.
• W2004662209 creator A5012140656 @default.
• W2004662209 creator A5013168913 @default.
• W2004662209 creator A5021050696 @default.
• W2004662209 creator A5028014140 @default.
• W2004662209 creator A5033582319 @default.
• W2004662209 creator A5040761076 @default.
• W2004662209 creator A5041226873 @default.
• W2004662209 creator A5046742541 @default.
• W2004662209 creator A5057888225 @default.
• W2004662209 creator A5061392802 @default.
• W2004662209 creator A5069210561 @default.
• W2004662209 creator A5071810251 @default.
• W2004662209 creator A5089616237 @default.
• W2004662209 date "2004-11-01" @default.
• W2004662209 modified "2023-09-27" @default.
• W2004662209 title "Continuity in the Treatment of Carotid Artery Disease: Results of a Carotid Stenting Program Initiated by Vascular Surgeons" @default.
• W2004662209 cites W1557604963 @default.
• W2004662209 cites W1973352840 @default.
• W2004662209 cites W2012650614 @default.
• W2004662209 cites W2024001639 @default.
• W2004662209 cites W2030797448 @default.
• W2004662209 cites W2036096037 @default.
• W2004662209 cites W2072949484 @default.
• W2004662209 cites W2076822791 @default.
• W2004662209 cites W2083887066 @default.
• W2004662209 cites W2091789730 @default.
• W2004662209 cites W2144088700 @default.
• W2004662209 cites W2152362972 @default.
• W2004662209 cites W2154316676 @default.
• W2004662209 cites W2169527012 @default.
• W2004662209 cites W2520005419 @default.
• W2004662209 cites W4382393309 @default.
• W2004662209 doi "https://doi.org/10.1007/s10016-004-0101-y" @default.
• W2004662209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15599624" @default.
• W2004662209 hasPublicationYear "2004" @default.
• W2004662209 type Work @default.
• W2004662209 sameAs 2004662209 @default.
• W2004662209 citedByCount "6" @default.
• W2004662209 countsByYear W20046622092017 @default.
• W2004662209 crossrefType "journal-article" @default.
• W2004662209 hasAuthorship W2004662209A5012140656 @default.
• W2004662209 hasAuthorship W2004662209A5013168913 @default.
• W2004662209 hasAuthorship W2004662209A5021050696 @default.
• W2004662209 hasAuthorship W2004662209A5028014140 @default.
• W2004662209 hasAuthorship W2004662209A5033582319 @default.
• W2004662209 hasAuthorship W2004662209A5040761076 @default.
• W2004662209 hasAuthorship W2004662209A5041226873 @default.
• W2004662209 hasAuthorship W2004662209A5046742541 @default.
• W2004662209 hasAuthorship W2004662209A5057888225 @default.
• W2004662209 hasAuthorship W2004662209A5061392802 @default.
• W2004662209 hasAuthorship W2004662209A5069210561 @default.
• W2004662209 hasAuthorship W2004662209A5071810251 @default.
• W2004662209 hasAuthorship W2004662209A5089616237 @default.
• W2004662209 hasConcept C126322002 @default.
• W2004662209 hasConcept C127413603 @default.
• W2004662209 hasConcept C139059822 @default.
• W2004662209 hasConcept C141071460 @default.
• W2004662209 hasConcept C164705383 @default.
• W2004662209 hasConcept C2776268601 @default.
• W2004662209 hasConcept C2777495988 @default.
• W2004662209 hasConcept C2777953023 @default.
• W2004662209 hasConcept C2778283817 @default.
• W2004662209 hasConcept C2778333808 @default.
• W2004662209 hasConcept C2778583881 @default.
• W2004662209 hasConcept C2779169563 @default.
• W2004662209 hasConcept C2779745121 @default.
• W2004662209 hasConcept C2780007028 @default.
• W2004662209 hasConcept C2780326628 @default.
• W2004662209 hasConcept C2780645631 @default.
• W2004662209 hasConcept C2781068581 @default.
• W2004662209 hasConcept C42219234 @default.
• W2004662209 hasConcept C71924100 @default.
• W2004662209 hasConcept C78519656 @default.
• W2004662209 hasConcept C84393581 @default.
• W2004662209 hasConceptScore W2004662209C126322002 @default.
• W2004662209 hasConceptScore W2004662209C127413603 @default.
• W2004662209 hasConceptScore W2004662209C139059822 @default.
• W2004662209 hasConceptScore W2004662209C141071460 @default.
• W2004662209 hasConceptScore W2004662209C164705383 @default.
• W2004662209 hasConceptScore W2004662209C2776268601 @default.
• W2004662209 hasConceptScore W2004662209C2777495988 @default.
• W2004662209 hasConceptScore W2004662209C2777953023 @default.
• W2004662209 hasConceptScore W2004662209C2778283817 @default.
• W2004662209 hasConceptScore W2004662209C2778333808 @default.
• W2004662209 hasConceptScore W2004662209C2778583881 @default.
• W2004662209 hasConceptScore W2004662209C2779169563 @default.
• W2004662209 hasConceptScore W2004662209C2779745121 @default.
• W2004662209 hasConceptScore W2004662209C2780007028 @default.
• W2004662209 hasConceptScore W2004662209C2780326628 @default.
• W2004662209 hasConceptScore W2004662209C2780645631 @default.
• W2004662209 hasConceptScore W2004662209C2781068581 @default.
• W2004662209 hasConceptScore W2004662209C42219234 @default.
• W2004662209 hasConceptScore W2004662209C71924100 @default.
• W2004662209 hasConceptScore W2004662209C78519656 @default.
• W2004662209 hasConceptScore W2004662209C84393581 @default.
• W2004662209 hasIssue "6" @default.

• next